查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654145

電泳市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測，2025-2030 年

Electrophoresis Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

電泳市場規模及趨勢

預計 2024 年全球電泳市場規模為 32.9 億美元，2025 年至 2030 年複合年成長率為 5.62%。

市場成長的動力在於對先進診斷工具的需求不斷成長、對生物技術和醫學研究的投資不斷增加以及對高效蛋白質和核酸分析的需求不斷成長。電泳在藥物開發、疾病診斷和研究等各種應用中發揮關鍵作用，推動了對更複雜、高性能系統的需求。隨著生物技術、製藥和學術領域繼續關注精準醫療和基因研究，對可靠、高效的電泳系統來分離和分析蛋白質、DNA 和 RNA 的需求日益增加。

成長的主要動力之一是技術的不斷進步。自動化系統的發展提高了實驗效率和可重複性，使得世界各地的實驗室擴大採用這些技術。此外，高解析度電泳和連接複用功能整合等技術創新提高了這些系統的靈敏度和吞吐量。這些進步使得電泳技術更加普及、用途更加廣泛，可以滿足臨床診斷、學術研究和生物製藥等各行業不斷變化的需求。例如，安捷倫ProteoAnalyzer系統是一個專為蛋白質分析而設計的先進的自動化平行毛細管電泳平台。這項創新解決方案簡化並最佳化了複雜蛋白質混合物的分析，服務於製藥、生物技術、食品分析和學術研究等廣泛的產業。

對個人化醫療和標靶治療的日益關注也是推動市場成長的關鍵因素。隨著醫療保健轉向更加個人化治療，基因檢測、生物標記識別和分子診斷已成為醫學研究和臨床實踐的重要組成部分。電泳在這些領域發揮著至關重要的作用，可以精確分離和分析生物分子，用於檢測疾病、選擇治療方法和監測治療結果。預計基因檢測需求的不斷成長以及電泳在腫瘤學、神經病學和其他治療領域的日益廣泛應用將進一步推動市場成長。

此外，推動電泳產業發展的另一個關鍵因素是臨床實驗室和診斷中心的需求不斷增加。隨著越來越多的臨床實驗室採用電泳技術進行常規檢測和疾病診斷，尤其是在基因檢測、血液分析和蛋白質分析領域，市場正在穩步擴大。此外，癌症、糖尿病和心血管疾病等慢性疾病的發生率不斷上升，需要精確的分子診斷技術進行早期檢測，這也推動了對基於電泳的系統的需求。

此外，製藥和生技公司也大力投資研發，以發現新藥和治療方法，幫助開發市場。電泳廣泛應用於藥物開發過程，從篩檢潛在的候選藥物到分析蛋白質交互作用和表徵治療性抗體。隨著製藥公司繼續專注於創造創新生技藥品，對具有高性能分析和深入蛋白質分析能力的先進系統的需求日益增加。這種成長在電泳對於複雜分子分析至關重要的領域尤其明顯，例如單株抗體開發和基因治療。

然而，先進系統及其維護的高成本是市場成長的主要限制因素。這些系統，尤其是高通量或自動化平台，通常需要大量的資本投資、專門的設備和熟練的人員來操作，這使得預算有限的小型實驗室或新興市場無法使用它們。此外，某些電泳技術的複雜性可能會導致冗長的訓練時間，如果管理不善，可能會出現錯誤。雖然這些系統提供了很高的準確性和效率，但其成本和營運要求可能會限制其採用，尤其是在資源匱乏的環境中。此外，一些地區的技術採用速度緩慢，再加上監管障礙和監管核准的需求，可能會阻礙某些地區的市場成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章電泳市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 電泳市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析

第 4 章 電泳市場：產品特定、估計與趨勢分析

  • 全球電泳市場：產品儀表板
  • 全球電泳市場：產品差異分析
  • 全球電泳市場（按產品和收益）
  • 電泳試劑
    • 蛋白質電泳試劑
    • 核酸電泳試劑
  • 電泳系統
    • 凝膠電泳系統
    • 毛細管電泳系統
  • 凝膠成像系統
  • 軟體

第 5 章 電泳市場：按應用進行的估計和趨勢分析

  • 全球電泳市場：應用儀表板
  • 全球電泳市場：應用趨勢分析
  • 全球電泳市場按應用和收益
  • 研究用途
  • 診斷用途
  • 品管和製程檢驗

第 6 章電泳市場：最終用途、估計和趨勢分析

  • 全球電泳市場：最終用途儀表板
  • 全球電泳市場：最終用途變化分析
  • 全球電泳市場按最終用途和收益
  • 學術研究所
  • 製藥和生物技術公司
  • 醫院和診斷中心
  • 其他

第 7 章電泳市場：按產品、應用、最終用途和地區進行的估計和趨勢分析

  • 區域控制面板
  • 市場規模、預測趨勢分析，2018-2030
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商概況
    • 主要經銷商及通路夥伴名單
    • 2024 年主要企業的市場佔有率分析
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Agilent Technologies, Inc.
    • Merck KGaA
    • GE Healthcare
    • QIAGEN
    • Lonza Group Ltd.
    • PerkinElmer, Inc.
    • Danaher
    • Harvard Bioscience, Inc.
    • Shimadzu Corporation
Product Code: GVR-4-68040-344-0

Electrophoresis Market Size & Trends:

The global electrophoresis market size was estimated at USD 3.29 billion in 2024 and is projected to grow at a CAGR of 5.62% from 2025 to 2030. The growth of the market is attributed to the increasing demand for advanced diagnostic tools, rising investments in biotechnology and healthcare research, and the growing need for efficient protein and nucleic acid analysis. Electrophoresis plays a critical role in various applications such as drug development, disease diagnosis, and research, driving the demand for more sophisticated, high-throughput systems. As the biotechnology, pharmaceutical, and academic sectors continue to focus on precision medicine and genetic research, the need for reliable and efficient electrophoresis systems to separate and analyze proteins, DNA, and RNA is on the rise.

One of the major drivers of growth is the continuous advancements in technology. The development of automated systems, which enhance the efficiency and reproducibility of experiments, is increasing the adoption of these techniques across laboratories worldwide. Additionally, innovations such as high-resolution electrophoresis and the integration of multiplexing capabilities are improving the sensitivity and throughput of these systems. With these advancements, electrophoresis is becoming more accessible and versatile, capable of meeting the evolving demands of various industries, including clinical diagnostics, academic research, and biopharmaceuticals. For instance, the Agilent ProteoAnalyzer system, which is an advanced automated parallel capillary electrophoresis platform designed for protein analysis. This innovative solution streamlines and optimizes the analysis of complex protein mixtures, serving a wide range of industries including pharmaceuticals, biotechnology, food analysis, and academic research.

The rising emphasis on personalized medicine and targeted therapies is another significant factor driving the growth of the market. As healthcare shifts towards more tailored treatments, genetic testing, biomarker identification, and molecular diagnostics have become essential components of medical research and clinical practice. Electrophoresis plays an integral role in these areas, enabling the precise separation and analysis of biomolecules that can be used for disease detection, treatment selection, and monitoring therapeutic efficacy. The increasing demand for genetic testing and the expanding use of electrophoresis in oncology, neurology, and other therapeutic areas are expected to further fuel market growth.

Furthermore, another key factor driving the electrophoresis industry is the increasing demand from clinical laboratories and diagnostic centers. As more clinical laboratories adopt electrophoresis techniques for routine testing and disease diagnosis, particularly in the areas of genetic testing, blood analysis, and protein profiling, the market is experiencing a steady uptick in adoption. Additionally, the rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular diseases, which require precise molecular diagnostic techniques for early detection, further contributes to the demand for electrophoresis-based systems.

Moreover, Pharmaceutical and biotechnology companies are also contributing to the market expansion by investing heavily in research and development (R&D) to discover new drugs and therapies. Electrophoresis is widely used in the drug development process, from screening potential drug candidates to analyzing protein interactions and characterizing therapeutic antibodies. As pharmaceutical companies continue to focus on creating innovative biologic drugs, the demand for advanced systems capable of high-throughput analysis and detailed protein profiling is rising. This growth is particularly evident in areas such as monoclonal antibody development and gene therapy, where electrophoresis is crucial for analyzing complex molecules.

However, the high cost associated with advanced systems and their maintenance is a major restraining factor for growth of the market. These systems, particularly high-throughput or automated platforms, often require significant capital investment, specialized equipment, and skilled personnel for operation, making them less accessible to smaller laboratories or those in emerging markets with limited budgets. Additionally, the complexity of certain electrophoresis techniques can result in longer training periods and potential errors if not properly managed. While these systems offer superior accuracy and efficiency, their cost and operational demands can limit adoption, particularly in low-resource settings. Furthermore, the slow pace of technology adoption in some regions, coupled with regulatory barriers and the need for regulatory approvals, can hinder market growth in certain areas.

Global Electrophoresis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global electrophoresis market report based on product, application, end Use, and region.

  • Product Outlook (Revenue, USD Million; 2018 - 2030)
  • Electrophoresis Reagents
    • Protein Electrophoresis Reagents
    • Nucleic Acid Electrophoresis Reagents
  • Electrophoresis Systems
    • Gel Electrophoresis Systems
    • Capillary Electrophoresis Systems
  • Gel Documentation Systems
  • Software
  • Application Outlook (Revenue, USD Million; 2018 - 2030)
  • Research Applications
  • Diagnostics Applications
  • Quality Control and Process Validation
  • End Use Outlook (Revenue, USD Million; 2018 - 2030)
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospital and Diagnostic Centers
  • Other End Use
  • Regional Outlook (Revenue, USD Million; 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End Use outlook
  • 2.3. Competitive Insights

Chapter 3. Electrophoresis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases
      • 3.2.1.2. Increasing industry academia collaborations
      • 3.2.1.3. Rising need for personalized medicines
      • 3.2.1.4. Technological advancements
      • 3.2.1.5. Increasing funding for genomics and proteomics research
      • 3.2.1.6. Rising number of clinical laboratories
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Untrained personnel
      • 3.2.2.2. Stringent regulations
  • 3.3. Electrophoresis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Electrophoresis Market: Product Estimates & Trend Analysis

  • 4.1. Global Electrophoresis Market: Product Dashboard
  • 4.2. Global Electrophoresis Market: Product Movement Analysis
  • 4.3. Global Electrophoresis Market by Product , Revenue
  • 4.4. Electrophoresis Reagents
    • 4.4.1. Electrophoresis reagents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Protein Electrophoresis Reagents
      • 4.4.2.1. Protein electrophoresis reagents market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Nucleic Acid Electrophoresis Reagents
      • 4.4.3.1. Nucleic acid electrophoresis reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Electrophoresis Systems
    • 4.5.1. Electrophoresis systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Gel Electrophoresis Systems
      • 4.5.2.1. Electrophoresis systems market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Capillary Electrophoresis Systems
      • 4.5.3.1. Capillary electrophoresis systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Gel Documentation Systems
    • 4.6.1. Gel documentation systems market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Software
    • 4.7.1. Software market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Electrophoresis Market: Application Estimates & Trend Analysis

  • 5.1. Global Electrophoresis Market: Application Dashboard
  • 5.2. Global Electrophoresis Market: Application Movement Analysis
  • 5.3. Global Electrophoresis Market by Application, Revenue
  • 5.4. Research Applications
    • 5.4.1. Research applications market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Diagnostics Applications
    • 5.5.1. Diagnostics applications market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Quality Control and Process Validation
    • 5.6.1. Quality control and process validation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Electrophoresis Market: End Use Estimates & Trend Analysis

  • 6.1. Global Electrophoresis Market: Ens-use Dashboard
  • 6.2. Global Electrophoresis Market: End Use Movement Analysis
  • 6.3. Global Electrophoresis Market by End Use, Revenue
  • 6.4. Academic and Research Institutes
    • 6.4.1. Academic and research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Pharmaceutical and Biotechnology Companies
    • 6.5.1. Pharmaceutical and biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Hospital and Diagnostic Centers
    • 6.6.1. Hospital and diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Other End Use
    • 6.7.1. Other end use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Electrophoresis Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Bio-Rad Laboratories, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Thermo Fisher Scientific Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Agilent Technologies, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Merck KGaA
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. GE Healthcare
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. QIAGEN
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Lonza Group Ltd.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. PerkinElmer, Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Danaher
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Harvard Bioscience, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Shimadzu Corporation
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 4 Global Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 5 Global Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Oncology Companion Diagnostic, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Oncology Companion Diagnostic, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 9 North America Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 10 North America Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 12 U.S. Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 13 U.S. Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 15 Canada Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 16 Canada Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Mexico Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 18 Mexico Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 19 Mexico Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Europe Oncology Companion Diagnostic, by Country, 2018 - 2030 (USD Million)
  • Table 21 Europe Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 22 Europe Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 23 Europe Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 24 Germany Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 25 Germany Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 26 Germany Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 27 UK Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 28 UK Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 29 UK Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 30 France Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 31 France Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 32 France Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Italy Oncology Companion Diagnostic, by Product, 2018 - 2030 (USD Million)
  • Table 34 Italy Oncology Companion Diagnostic, by Application, 2018 - 2030 (USD Million)
  • Table 35 Italy Oncology Companion Diagnostic, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Spain Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 37 Spain Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 38 Spain Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Denmark Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 40 Denmark Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 41 Denmark Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 42 Sweden Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 43 Sweden Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 44 Sweden Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Norway Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 46 Norway Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 47 Norway Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Electrophoresis, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 52 China Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 53 China Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 54 China Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Japan Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 56 Japan Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 57 Japan Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 58 India Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 59 India Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 60 India Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 61 South Korea Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 62 South Korea Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 63 South Korea Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Australia Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 65 Australia Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 66 Australia Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Thailand Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 68 Thailand Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 69 Thailand Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 70 Latin America Electrophoresis, by Country, 2018 - 2030 (USD Million)
  • Table 71 Latin America Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 72 Latin America Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 73 Latin America Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 74 Brazil Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 75 Brazil Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 76 Brazil Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 78 Argentina Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 79 Argentina Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Electrophoresis, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 85 South Africa Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 90 UAE Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 91 UAE Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 92 UAE Electrophoresis, by End Use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Electrophoresis, by Product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Electrophoresis, by Application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Electrophoresis, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Electrophoresis Market Segmentation
  • FIG. 8 Market Snapshot, 2023
  • FIG. 9 Market Trends & Outlook
  • FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Global Electrophoresis Market: Product Movement Analysis
  • FIG. 16 Global Electrophoresis Market, for Electrophoresis Reagents, 2018 - 2030 (USD Million)
  • FIG. 17 Global Electrophoresis Market, for Electrophoresis Systems, 2018 - 2030 (USD Million)
  • FIG. 18 Global Electrophoresis Market, for Gel Documentation Systems, 2018 - 2030 (USD Million)
  • FIG. 19 Global Electrophoresis Market, for Software, 2018 - 2030 (USD Million)
  • FIG. 20 Global Electrophoresis Market: Application Movement Analysis
  • FIG. 21 Global Electrophoresis Market, for Research Applications, 2018 - 2030 (USD Million)
  • FIG. 22 Global Electrophoresis Market, for Diagnostics Applications, 2018 - 2030 (USD Million)
  • FIG. 23 Global Electrophoresis Market, for Quality Control and Process Validation, 2018 - 2030 (USD Million)
  • FIG. 24 Global Electrophoresis Market: End Use Movement Analysis
  • FIG. 25 Global Electrophoresis Market, for Academic and Research Institutes, 2018 - 2030 (USD Million)
  • FIG. 26 Global Electrophoresis Market, for Pharmaceutical and Biotechnology Companies, 2018 - 2030 (USD Million)
  • FIG. 27 Global Electrophoresis Market, for Hospital and Diagnostic Centers, 2018 - 2030 (USD Million)
  • FIG. 28 Global Electrophoresis Market, for Other End Use, 2018 - 2030 (USD Million)
  • FIG. 29 Regional Marketplace: Key Takeaways
  • FIG. 30 Regional Outlook, 2023 & 2030
  • FIG. 31 Global Electrophoresis Market: Region Movement Analysis
  • FIG. 32 North America Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 33 U.S. Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 34 Canada Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 35 Mexico Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 36 Europe Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 37 Germany Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 38 UK Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 39 France Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 40 Italy Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 41 Spain Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 42 Denmark Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 43 Sweden Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 44 Norway Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 45 Asia Pacific Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 46 Japan Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 47 China Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 48 India Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 49 Australia Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 50 South Korea Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 51 Thailand Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 52 Latin America Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 53 Brazil Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 54 Argentina Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 55 Middle East and Africa Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 56 South Africa Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 57 Saudi Arabia Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 58 UAE Electrophoresis Market, 2018 - 2030 (USD Million)
  • FIG. 59 Kuwait Electrophoresis Market, 2018 - 2030 (USD Million)